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1. Introduction 
1.1 Neurodegeneration involve different cell types 
Neurodegeneration is a complex process involving different cell types and 
neurotransmitters. A common characteristic of neurodegenerative disorders such as 
Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis, Huntington’s disease 
(HD) and Amyotrophic Lateral Sclerosis (ALS) is the occurrence of a neuroinﬂammatory 
reaction in which cellular processes involving glial cells (mainly microglia and astrocytes) 
and T cells are activated in response to neuronal death. This inﬂammatory reaction has 
recently received attention as an unexpected potential target for the treatment of these 
diseases.  
Microglial cells have a mesenchymal origin, invade the central nervous system (CNS) 
prenatally (Chan et al., 2007b) and are the resident macrophages in the CNS (Ransohoff & 
Perry, 2009). They comprise approximately 10-20% of adult glia and serve as the CNS innate 
immune system. In neurodegenerative diseases, microglia is activated by misfolded 
proteins. In the case of AD, amyloid-ǃ (Aǃ) peptides accumulate extracellularly and activate 
the microglia locally. In the case of PD, ALS and HD, the misfolded proteins accumulate 
intracellularly but are still associated with activation of the microglia (Perry et al., 2010). 
Reactive microglia in the substantia nigra and striatum of PD brains have been described, 
and increased levels of proinflammatory cytokines and inducible nitric oxide synthase have 
been detected in these brain regions, providing evidence of a local inflammatory reaction 
(Hirsch & Hunot, 2009). The injection of lipopolysaccharide (a potent microglia activator) 
into the substantia nigra produces microglial activation and the death of dopaminergic cells. 
These findings support the hypothesis that microglial activation and neuroinflammation 
contribute to PD pathogenesis (Herrera et al., 2000).  
Astrocytes are ectodermal cells, and they are probably about ten times as numerous as 
neurons. Astroglial cells were initially believed to be passive support cells providing trophic 
support for surrounding neurons (Sofroniew & Vinters, 2010), maintaining extracellular ion 
homeostasis and capturing excess extracellular neurotransmitters such as glutamate, which 
is considered particularly important given its involvement in excitotoxicity. However, recent 
studies have implicated astrocytes in many complex CNS functions, such as physical 
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structuring of the brain (they are the main cells involved in cholesterol synthesis), active 
control of synaptogenesis and plasticity (Graeber, 2010), regulation of blood flow and 
promotion of myelination (Halliday & Stevens, 2011). Astroglial activation is characterized 
by an increase in expression of intermediate ﬁlament glial ﬁbrillary acidic protein (GFAP) 
and the gene aldehyde dehydrogenase 1 family member L1 (ALDH1L1). Astrocytes are not 
immune cells per se, but they can, under speciﬁc conditions, contribute to the immune 
response (Farina et al., 2007).  
Several other cell types have been associated with neurodegeneration and 
neuroinﬂammation, such as T-cells, oligodendrocytes and ependymal and subependymal 
cells (Philips & Robberecht, 2011). Once inﬁltrated in the CNS, T-cell subpopulations 
modulate the neuroinﬂammatory reaction differently, depending on stage of disease 
progression (Beers et al., 2011, Philips & Robberecht, 2011). Oligodendrocyte cells are widely 
distributed in the adult nervous system and their precursors have been reported to 
differentiate into astrocytes and even neurons in speciﬁc conditions (Rivers et al., 2008); 
however, their role in neuroinﬂammation is still poorly understood, as is that of ependymal 
and subependymal (Chi et al., 2006). 
In addition to the death of specific neuronal populations, there are many other parallels 
between different neurodegenerative disorders. These include alteration of a diversity of 
neurotransmitters and intracellular signals, in particular of glutamate and calcium, which 
play key roles in excitotoxicity. Thus, alterations in cellular and molecular steady states give 
rise to changes that cannot be counteracted by the tissue, and lead to chronic and 
progressive neurodegenerative processes from which a return to normality is impossible. As 
advances in research are made, more similarities between these neurodegenerative diseases 
have been found on many different levels, from molecular to tissular. 
1.2 Inflammation and neurodegeneration  
The term neuroinflammation describes endogenous CNS tissue response to injury. 
Classically known as reactive gliosis, neuroinflammation refers to the aggressive response of 
glia to activating stimuli, analogous to the response of activated immune cells in peripheral 
tissues. Neuroinflammation has been associated with chronic CNS diseases such as multiple 
sclerosis, which is an unequivocal example of an inflammatory CNS disease. Other 
neurodegenerative diseases such as AD, ALS, PD, and HD lack the prominent infiltrates of 
blood-derived mononuclear cells that characterize autoimmune diseases. However, many 
substances involved in the promotion of inflammatory processes are present in the CNS of 
patients with such neurodegenerative diseases (Block et al., 2007). 
Microglia are transformed and activated by a range of signals, such as neuronal death, 
mechanical injury and toxins (Block et al., 2007, Streit et al., 2004), and once activated they 
form the ﬁrst line of defense against infection or injury to the CNS (Schwartz et al., 2006). 
Activated microglia acquire an amoeboid phenotype morphology similar to macrophages 
expressing the same markers, such as MHCI, MHCII, Iba1 and GLUT5 (Halliday & Stevens, 
2011), and secrete proinﬂammatory molecules such as tumor necrosis factor-alpha (TNF-α), 
interferon Ǆ, and interleukin 1ǃ; they also upregulate oxidant molecules such as nitric oxide 
(NO) and O2, which can protect against pathogens. This proinﬂammatory reaction 
eliminates hazards and repairs any damage. Microglia also release anti-inﬂammatory and 
trophic factors such as insulin-like growth factor 1 (IGF-1), interleukin 4, and interleukin 10, 
contributing to the repair and limitation of the inﬂammatory process (Block et al., 2007, Stoll 
et al., 2002). The proinﬂammatory or anti-inﬂammatory responses of the microglia are 
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inﬂuenced by surrounding astrocytes and inﬂammatory T-cell subsets, which can affect 
their phagocytic capacity and antigen-presenting cell properties. 
All neurological disorders lead to activation of the microglia. Thus, microglial reaction 
represents the main mediator of the inflammatory process in neurodegenerative diseases, 
and microgliosis is directly related to the physiopathology of these. For example, 
microgliosis is associated with atypical and insoluble components caused by irregular 
protein folding and degradation pathways, altered subcellular localization, and the 
abnormal interactions with other cellular proteins found in AD, PD HD, Down syndrome 
and normal aging. Microgliosis is also associated with the formation of extracellular ionic 
precipitates, such as hydroxyapatites, which are frequently observed within the CNS areas 
involved in the disease (Rodriguez et al., 2009a, Saura et al., 1995), and is also present in 
encephalopathies caused by prions. This innate immune response is currently considered to 
be a potential pathogenic factor, since microglial reaction may engender neurodegenerative 
events, including amyloid-beta plaque formation, dystrophic neurite growth, and excessive 
tau phosphorylation. 
1.3 Microglial reaction: Two sides of the same coin  
In the healthy CNS, ramified resting microglia are active cells since they permanently scan 
their microenvironment (Wake et al., 2009). In response to any CNS injury or immunological 
stimuli, the microglia rapidly evolve from a surveillance state towards a more reactive one, 
through important phenotypical changes in response to activation signals released by the 
tissue (Schwartz et al., 2006). Microglia undergo a dramatic morphological transformation 
into amoeboid form and express an upregulated catalogue of molecules, such as CD14, 
major histocompatibility complex (MHC) molecules, chemokine receptors, CD11c, integrins, 
neurotrophins, and several other markers (Kettenmann et al., 2011). As such, reactive 
microglia can perform functions essential to neuron survival, such as phagocytosis to clear 
toxic and cellular debris, and innate immunity. Also involved in the release of trophic and 
anti-inflammatory factors, microglia facilitate repair through the guided migration of stem 
cells to the site of inflammation and injury. 
In contrast, once microglia become overactivated they can produce detrimental effects 
through excessive production of a large array of cytotoxic factors, such as NO, TNF-α, 
reactive oxygen species, and pro-inflammatory cytokines (Lull & Block, 2010, Milligan & 
Watkins, 2009). Currently, the conditions that determine whether microglial reaction will be 
detrimental or beneficial to neuronal survival are poorly understood. However, it is 
becoming more widely accepted that although microglial activation is necessary and crucial 
for host defense and neuron survival, microglial overactivation leads to deleterious 
consequences.  
Since every single microglial cell generates its own response to damage according to the 
nature and intensity of the signals released by the injured tissue, microglial cells do not 
constitute a homogenous cell population, but instead present a range of different 
phenotypes closely related to the evolution of the lesion process. In addition, some 
microglial cells become increasingly dysfunctional as they age, and may participate directly 
in the development of neurodegeneration (Block et al., 2007, Stoll et al., 2002). Microglia 
adopts a phenotype that mostly exacerbates tissue injury or promotes brain repair. 
Microglia can thus present two phenotypes, one of which is deleterious (also called M1 
microglial phenotype) and the other benign (M2 microglial phenotype), depending on their 
intrinsic properties, interaction with the cellular microenvironment, and presence of 
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pathogenic factors (Halliday & Stevens, 2011, Henkel et al., 2009). Therefore, controlling 
microglial cell activation and the acquisition of positive or negative phenotypes is of major 
therapeutic interest in all CNS disorders related to neuroinflammation.  
1.4 Astrocyte-microglia interactions: Who’s the bad guy after all? 
The classical view of astroglia, as simply presenting non-excitable support to neurons, has 
changed radically in recent years. Astrocytes are now seen as elements that generate various 
local signals, including glutamate, to communicate with neurons and that influence the 
tissue outcome during neurodegeneration (Allaman et al., 2011). There is increasing evidence 
in support of this active role of astrocytes, suggesting that atypical astrocyte activation or 
astroglial dysfunction constitute maladaptive responses to brain injury that may feed the on-
going pathologic process during neurodegeneration. For example, astrocyte dysfunction is a 
key factor in the pathogenesis of human neurological disorders (Seifert et al., 2006), and in 
the cognitive impairment of aged rats (Andrés et al., 2000). Furthermore, glutamate-induced 
chronic lesion in rat brain not only presents a lack of astrogliosis but also long term atrophy 
of astrocytes, suggesting a maladaptive response that may be a cause of the on-going 
pathologic process (Rodriguez et al., 2009a). 
Moreover, astrocytes influence microglial behaviour (figure 1). For instance, astrocytes play 
a critical role in the activation of microglia under infectious conditions (Ovanesov et al., 
2008). In addition, astroglial chemokines are involved in microglia/macrophage activation 
in multiple sclerosis with MCP-1/CCL2 and IP-10/CXCL10 directing reactive gliosis 
(Tanuma et al., 2006). Therefore, it is reasonable to assume that astrocytic activity can be 
influenced by microglial activation. Although a clear account of this dynamic relationship 
has yet to be proposed, the astrocyte-microglia interplay may determine the phenotype that 
microglial cells adopt during neurodegeneration.  
Some findings have implicated astrocytes in chronic microgliosis, with a transition from an 
initial neuroprotective activity to a later cytotoxic one. TNF-α secretion is crucial for rapid 
autocrine microglial activation with both neuroprotective and cytotoxic effects, a process 
that is also fed by TNF-α released by reactive astrocytes (Suzumura et al., 2006). TNF-α 
actions leading to neuronal death or survival are dose dependent (Bernardino et al., 2008), 
since it can activate two specific receptors: TNFR1, with an intracellular death domain, and 
TNFR2, mainly involved in neuroprotection (Fontaine et al., 2002). Consequently, low 
concentrations of TNF-α would initially induce TNFR2-mediated neuroprotection, whereas 
a subsequent high concentration of TNF-α would be able to activate TNFR1 both in 
astrocytes and microglia and contribute to cell injury through the death domain of the 
receptor.  
Astroglial S100ǃ is another of the factors that control microglial activity. Astrocytes release 
S100ǃ constitutively (Van Eldik & Wainwright, 2003) and increase this release upon 
stimulation by several factors, including TNF-α (Edwards & Robinson, 2006). Under normal 
conditions, released S100ǃ acts as a neurotrophic factor, countering the stimulatory effect of 
neurotoxins on (Reali et al., 2005) and stimulating astrocyte glutamate uptake (Tramontina 
et al., 2006). Released S100ǃ modifies astrocytic, neuronal and microglial activities, 
depending on the extracellular concentration of the former and the expression of the specific 
receptor for advanced glycation end-products (RAGE). At micromolar concentrations, S100ǃ 
upregulates IL-1ǃ and TNF-α expression in activated microglia via RAGE, with the 
requirement of concurrent activation of NF-κB and AP-1 transcription factors (Bianchi et al., 
2010). Furthermore, factors that modulate microglial reactivity, such as Ca2+ concentration,  
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Fig. 1. Signalling systems in the microglia-astrocyte-neuron cross-talk. Astrocytes and 
microglia monitorize neuronal activity by sensing neurotransmitter release. In the same 
way, microglial cells have receptors to molecules released by astrocytes. Microglia integrate 
all these signals and release molecules that may modulate neuronal and astroglial activity. 
During neurodegeneration, changes in physiological parameters may trigger neuronal 
injury and/or microglial activation (molecules inside a red square) that modify those signal 
transduction systems. Aβ, amyloid beta; Ach, acetylcholine; Ado, adenosine; BDNF, Brain-
derived neurotrophic factor; GABA, γ-aminobutyric acid; GDNF, Glial cell-derived 
neurotrophic factor; Glc, glucose; Glu, glutamate; 5-HT, serotonin; VIP, Vasoactive intestinal 
peptide; IFNγ, interferon gamma; ROS, reactive oxygen species; Tau, taurine  
reactive oxygen species or TNF-α, also modify the RAGE response to S100ǃ (Edwards & 
Robinson, 2006) in a microglia-astroglia cross-talk that integrates these signaling systems. In 
contrast, at high concentrations S100ǃ binds the RAGE, which may mediate microglial 
activation during the course of brain damage (Bianchi et al., 2010). An increased release of 
S100ǃ during neurodegeneration (Li et al., 2011) will enhance inflammatory cytokine 
production and potentiate the switch of microglia to chronic cytotoxic activity, feeding the 
neurotoxic process and leading to neurodegeneration. 
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Thus, CNS neurodegeneration involves chronic microgliosis with a putative transition from 
an initial neuroprotective activity to a later cytotoxic one, with S100ǃ as a key modulator of 
microglial transition towards a cytotoxic response. This suggests a role for astrocytes in 
promoting the cytotoxic microglial phenotype through secretion of TNF-α, S100ǃ and other 
signals (Donato et al., 2009, Suzumura et al., 2006). In this scenario, the interplay between 
trophic, neuroprotective, inflammatory and cytotoxic functions of both cell types during 
brain injury will determine the evolution of the neurodegenerative process. Precise control 
of these processes thus requires a dynamic view of their interactions so as to allow effective 
development of approaches to neuroprotection. 
2. CNS calcification and neurodegeneration  
2.1 Enduring effects of excessive synaptic glutamate 
Glutamate accounts for most of the excitatory synaptic activity in the CNS and has been 
implicated in learning, memory, synaptic plasticity and neurotrophic activity processes. 
Glutamate receptors have been classified into three groups: two ionotropic groups -N-
methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
(AMPA)-kainate receptors-; and one group of metabotropic receptors, which are coupled to 
G proteins. Although non-NMDA receptors are not initially permeable to Ca2+, glutamate 
release in the synaptic cleft increases post-synaptic and glial membrane permeability, 
leading to a transient increase in intracellular Ca2+ concentration ([Ca2+]i) (Obrenovitch et al., 
2000).  
Excessive activation of glutamate receptors can trigger neuronal death through a process 
characterized by chronic glutamate release and the consequent [Ca2+]i dys-homeostasis in 
neurons and astrocytes (Arundine & Tymianski, 2004) and formation of [Ca2+]i precipitates, 
the size and number of which depends on the CNS area involved and CNS maturation 
(Bernal et al., 2000b, Rodríguez et al., 2001). This process, defined as excitotoxicity, also 
involves cellular influxes of Na+ and Cl- and efflux of K+, with ensuing cell swelling (Chen et 
al., 1998, Katayama et al., 1995). Because of the complexity and diversity of the processes 
taking place at the glutamatergic synapse, any disturbance at the pre-synaptic, post-
synaptic, or astroglial level may trigger a chronic excitotoxic process. For example, ALS 
presents a loss of selectivity of ionotropic receptors (Obrenovitch et al., 2000) and 
deficiencies in glial re-uptake of glutamate (Liévens et al., 2000). These glutamate-related 
dysfunctions contribute to explaining phenomena such as the aging-associated hypoactivity 
of NMDA receptors observed in AD (Olney et al., 1997), and the specific AMPA-receptor 
increment detected in the hippocampus of aged, cognitive-impaired rats (Le Jeune et al., 
1996).  
One of the consequences of excitotoxic-induced neuronal loss is the alteration of other 
neurotransmitter systems and neuromodulators. For example, long-term ibotenic-induced 
lesion in the basal forebrain of rat leads to a loss of cholinergic afferences and to decreased 
extracellular noradrenaline, glutamate, and taurine (Boatell et al., 1995). This cortical 
reduction in glutamatergic transmission presents a temporal pattern which, together with 
the development of Ca2+ precipitates and a decrease in the cholinergic and noradrenergic 
functions (Saura et al., 1995), mimics the neurochemical modifications described in AD. 
Similarly, one year after acute lesion, the cortical and hippocampal decrease in brain-
derived neurotrophic factor, fibroblastic growth factor and glucocorticoid receptor, and the 
increase in c-fos expression in the septal area were still significant (Boatell et al., 1992). Thus, 
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excitotoxic lesions in basal forebrain can modify long-term cortical adaptative responses, 
and may modulate the expression of glutamate receptor. Some of these effects, such as the 
decrease in brain-derived neurotrophic factor and the increase in c-fos expression, also 
reflect the molecular alterations present in AD. 
Given these toxic effects, adaptations that act to control glutamatergic neurotransmission 
and Ca2+ movements in the cell may be potentially protective. Over time, these defenses are 
developed to act at any time during an excitotoxic event, involve different cellular types 
such as neurons, astrocytes and microglia, and deal with the cellular and molecular 
mechanisms of glutamatergic neurotransmission. These mechanisms include defenses that: 
a) decrease neuronal excitability, b) decrease glutamate accumulation in the synapse, c) limit 
Ca2+ mobilization in the postsynaptic neuron and protect against calcium-dependent 
degenerative effects, and d) enhance neuronal energy (Rodriguez et al., 2009b, Sapolsky, 
2001). 
If the compensatory mechanisms are not sufficiently effective, the initial acute neuronal 
injury due to an increase in [Ca2+]i leads, with time, to a chronic lesion. This secondary 
excitotoxicity appears in neurons after the massive entrance of Ca2+ and Na+ through 
ionotropic glutamate receptors, an entrance that is supplemented by Ca2+ release from the 
endoplamic reticulum following activation of mGluRs. As a result, an excessive [Ca2+]i 
increment occurs (Verkhratsky, 2007), which activates the mechanisms triggering neuronal 
death. Ca2+ extrusion and buffering are activated when [Ca2+]i increases (Mattson & Chan, 
2003), with high expenditure of energy through Ca2+-ATPases. (Figure 4). 
Calcium homeostasis disturbances are present in all neurodegenerative disorders (Mattson, 
2006). Dysregulation of Ca2+ homeostasis alters the rapid and coherent activation of 
neurons, and is therefore ultimately responsible for many aspects of brain dysfunction and 
CNS diseases. For example, an increased rate of Ca2+-mediated apoptosis may cause 
neuronal death in the penumbra of cerebral ischemia, or may underlie the etiology of 
chronic neurodegenerative disorders such as PD and AD. Calcium precipitation that 
coincides with microglial activation, amyloid deposits and other ion accumulations in AD 
may thus be a key element of the neurodegenerative process (Ramonet et al., 2006). 
2.2 Neurodegeneration as a result of disturbances in calcium homeostasis 
Regulation of intraneuronal Ca2+ movements is a key element to ensure adequate cellular 
response at all times and produce a physiological effect. Ca2+ participates in most cellular 
functions, including membrane excitability and secretion, energy production, synaptic 
transmission, gene regulation and plasticity, cell proliferation and cell death (Arundine & 
Tymianski, 2003). As a consequence, cell function requires tight control of Ca2+ homeostasis 
between extra- and intracellular compartments at all times, including the production of 
sufficient energy from glycolysis to maintain different gradient concentrations such as a 
1/10,000 inside-outside cell concentration (Verkhratsky, 2005). Most calcium within cells is 
sequestered in the mitochondria and the endoplasmic reticulum. Intracellular free calcium 
concentrations fluctuate widely, from roughly 100 nM to over 1 μM, due to release from 
cellular stores or influx from extracellular fluid. These fluctuations are integral to the role of 
calcium, and unless compensated for by some other mechanism, any dysregulation will 
have severe cellular consequences, the effects of which will be propagated to the 
surrounding cells, namely, neurons and glial cells (Beck et al., 2004). For example, activation 
of glutamate receptors by excitatory signals leads to a massive increase in cytoplasm Ca2+ 
levels, which in turn activates a cascade of events to produce a neuronal response. A return 
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to basal activity requires a considerable expenditure of energy to bring Ca2+ back to initial 
levels. Any failure in these multiple, coordinated steps will alter neuronal signalling and 
interfere with neuronal network functions (Rodriguez et al., 2009b).  
Reduction of [Ca2+]i involves a high mitochondrial intake of Ca2+ that may lead to loss of the 
mitochondrial membrane potential and the production of reactive oxygen species, thereby 
decreasing cellular respiratory capacity and ATP formation from ADP and Pi (Chan et al., 
2007a). As a result, there is an acceleration of anaerobic glycolysis with a net lactate 
production that contributes to tissue acidification and progression of damage. Disturbances 
in Ca2+ homeostasis in astrocytes reduce neuronal support, in particular through alteration 
of the glutamate/glutamine cycle and a reduction of glucose delivery to neurons (Pellerin et 
al., 2007, Ramonet et al., 2004) (Figure 4). Consequently, astrocyte dysfunction can lead to 
increased synaptic glutamate levels and glutamate receptor overactivation, combined with 
reduced neuronal energy, resulting in neuronal damage. Under these conditions of high 
Ca2+ and Pi and low ATP, formation of hydroxyapatite precipitates to reduce Ca2+ 
cytoplasm activity at low energy costs can occur in neurons and astrocytes (Rodriguez et al., 
2000). This new step in calcium homeostasis temporarily helps the cell to resist excessive 
stimulatory signals and return to basal activity by dissolving paracrystal elements. 
However, in most cases, the hydroxyapatite crystals show progressive growth and 
participate in cell death and CNS damage. 
Depending on the importance of the damage, microglial activation may take place, 
initially expressing neuroprotective signals to help avoid further neuronal death, but then 
changing progressively to an inflammatory phenotype (Graeber, 2010). Glycolysis, highly 
stimulated in microglia to ensure and maintain their activated stage, reduces neuronal 
glucose and oxygen availability. Consequently, microglial participation in neuronal death 
includes not only neuroinflammation, but also reduction in neuronal energy availability 
(Allaman et al., 2011). If, as asserted by Gyuri Buzsaki in Rhythms of the Brain (Buzsáki, 
2006), “Brains are foretelling devices and their predictive powers emerge from the various 
rhythms they perpetually generate”, any significant alteration of the neuronal rhythms 
caused by an abnormally high Ca2+ concentration in neurons or glia should alter the 
brain’s ability to pause, adapt and learn, and can lead to disease. This is the case of 
neurodegenerative diseases, which exhibit diverse clinical and neuropathological 
phenotypes but share the common feature of progressively reduced cell function and 
survival within the nervous system, leading to neurological disability and often death. As 
such, several different CNS disorders can be induced following the same injury, due to 
the multi-directional interactions between the neurons, glial cells, extracellular matrix, 
endothelia and host immune cells that regulate tissue homeostasis and orchestrate 
neuroinflammation and degeneration. Furthermore, the characteristics of each neuronal 
population and network, the different gliopathic changes occurring between CNS areas, 
the various microglia phenotypes and the abundance and distribution of glutamate 
receptor subtypes and of Ca2+-binding proteins, all participate directly in the properties of 
the neurodegenerative parameters (Graeber & Streit, 2010, Rodriguez et al., 2004, 
Rodriguez et al., 2009a) that will determine the dynamics and progression of the disease 
in the specific affected areas. For example, PD and AD are both regarded as diseases that 
are initiated by neuronal death to which the immune system responds, as evidenced by 
astroglial and microglial activation with pathogenic consequences (Agostinho et al., 2010, 
Halliday & Stevens, 2011). Similarly, multiple sclerosis is typically considered a 
neuroinflammatory disorder, but one in which neuronal injury plays an active role in 
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regulating neuroinflammation, as has been recently reported (Haider et al., 2011). In all of 
these diseases, dysregulation of Ca2+ homeostasis has been considered a pathophysiological 
factor linked to neuronal degeneration, and the formation of intracellular Ca2+ deposits 
with different characteristics as regards size and distribution - reflecting differential CNS 
area vulnerability - has frequently been reported (Hashimoto et al., 2003, Ramonet et al., 
2006). 
2.3 CNS calcification 
In immature human CNS, Ca2+-mediated excitotoxicity is associated with a calcification 
process that directly correlates with neuronal loss and the extent of injury. Revealed by 
Alizarin red staining and appearing in TEM and X-ray microanalyses of animal 
neurodegeneration models, small and large intracellular Ca2+ precipitates indicate the 
formation of a paracrystalline structure of hydroxyapatites localized within neurons and 
astrocytes (figure 2). 
Glutamate analog microinjection in rat CNS leads to an intracellular Ca2+ precipitation 
similar to brain calcification in humans (Ramonet et al., 2006, 2002). As these Ca2+ deposits 
can be observed in several areas of rat brain after microinjection of different excitotoxins 
(Bernal et al., 2000b, Rodriguez et al., 2000, Saura et al., 1995), their formation does not 
depend on the glutamate receptor subtype initially stimulated. However, their size, number 
and distribution vary with both the activated receptor and the CNS area. For example, 
sensitivity to AMPA-induced calcification decreased from the globus pallidus, cerebral 
cortex, hippocampus, medial septum, to retina (Rodriguez et al., 2000). Moreover, in medial 
septum, the degeneration associated with microinjection of ibotenic and quisqualic acids 
was characterized by significant atrophy and no calcification (Mahy et al., 1996, Saura et al., 
1995). In similar conditions, AMPA microinjection resulted in similar atrophy and Ca2+ 
deposits at the injection site (Rodriguez et al., 2009a).  
Ca2+ deposits do not occur in all cells that degenerate in response to excitotoxins. For 
example, in the basal forebrain and medial septum, the calcification observed in GABAergic 
cells was not detected in cholinergic neurons. The former, together with astrocytes, seem to 
participate actively in the calcification process (Mahy et al., 1999). Differences in the 
neuronal phenotype of Ca2+ buffering and extrusion systems, specific energy needs, 
expression of the glutamate subtype receptor and different astroglial populations, should 
explain this variability. The ultrastructural study of tissue affected by excitotoxicity has also 
contributed to our understanding of calcification. Ca2+ deposits within hypertrophied 
astrocytes have been characterized in the basal forebrain and hippocampus which ranged 
from 0.5 to 10 μm in diameter and were formed by numerous, small, needle-shaped crystals 
associated with cellular organelles, such as microtubules, cisternae, vesicles or 
mitochondria, with no signs of neurodegeneration (figure 2). Larger inclusions were 
surrounded by reactive microglia, a finding that was also observed in tissue after specific 
localization by in vitro autoradiography (Bernal et al., 2000b, Petegnief et al., 1999). X-ray 
microanalysis has shown an electron-diffraction ring pattern characteristic of a crystalline 
structure similar to apatites (Kim, 1995), and a Ca/P ratio of 1.3±0.2 of cytoplasmic deposits 
(Figure 2). This ratio, lower than the theoretical apatite value of 1.67, is also typical of 
biological crystals, which do not present an ideal organization (Rodriguez et al., 2000). As 
biological hydroxyapatites, these deposits are similar to those observed in several human 
peripheral nervous system tissues (Kodaka et al., 1994). 
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Fig. 2. Characterization of calcium deposits induced by ibotenic acid in the rat brain. 
Microphotographs of a) Nissl stained section of a rat hippocampus 15 days after the 
injection and b) Alizarin red stained section of the same hippocampus showing calcium 
deposits associated with the lesion. c-d) calcium deposits showed different sizes in the rat 
globus pallidus 2 months after injection. e) Isolectin B4 histochemistry (brown staining) 
counterstained with alizarin red showing the microglial reaction (arrowhead) associated 
with calcium deposits. f) Hypertrophic astrocyte with an intracytoplasmic calcium deposit 
by TEM. g) Detail of the ultrastructure of calcium deposit within an astrocyte. Note the 
normal appearance of the surrounding mitochondria (arrowhead). X-ray image h) and 
spectrum analysis i) of one calcium deposit in a non-osmificated sample with a calculated 
Ca/P ratio of 1.3. False colour X-ray image mapping j) and distribution plots k) of Ca and P 
of the same deposit. Bars; a-b, 1 mm; c, 100 μm; d-e, 20 μm; f, 0.6 μm, g, 0.2 μm; h, 10 μm 
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Experimental models of bone formation (i.e. hydroxyapatite formation in vitro) (Andre-Frei 
et al., 2000) have shown that rather than Ca2+, a minimal amount of phosphorus, as 
inorganic phosphate, is crucial for crystal nucleation in a collagen matrix. Similarly, organic 
phosphate residues of the phosphoproteins also play a direct and significant role in the 
process of in vitro nucleation of apatite by bone collagen, whereas collagen itself does not 
promote the precipitation of Ca2+ or phosphate (Andre-Frei et al., 2000). Therefore, 
excitotoxicity-induced calcification in the rat brain depends on an increase in intracellular 
inorganic phosphate (i.e. ATP depletion) and, most importantly, on the degree of protein 
phosphorylation. Thus, the Ca2+-binding-protein-dependent kinases and activity of the 
neurotrophic factor ultimately determine calcification. 
In aqueous solutions, hydroxyapatite crystallization takes place in two sequential steps 
(Barat et al., 2011): in the first, crystal nucleation occurs spontaneously with subsequent 
growth to some nanometers, when phosphate and Ca2+ ions reach a certain concentration; in 
the second step, an accretion process of these nanocrystals on a proteinic net takes place 
until reaching a maximum size of 20 micrometers. While the first process facilitates re-
solubilization of the crystal, the second produces a stable precipitate and requires a catalytic 
agent. These two mechanisms may help explain the size differences we found between 
several areas of the CNS. For example, the large insoluble Ca2+ precipitates (mean size 20 μm) found after AMPA microinjection in globus pallidus (Petegnief et al., 1999) fit well with 
the second step theory, whereas the small deposits (mean size lower than 3 μm) obtained in 
hippocampus after the same procedure (Rodriguez et al., 2004) may reflect the lack of a 
catalytic agent for accretion, or an equilibrium between crystal formation and solubilization. 
Furthermore, blockade of glial glutamate uptake in rat striatum (Liévens et al., 2000) 
produced a spherical lesion with a central necrotic core surrounded by a penumbra zone 
similar to that caused by focal ischemia. Three days after treatment, an astroglial reaction 
and small Ca2+ deposits (mean diameter < 1 μm) were observed in the penumbra area. 
Eleven days later, these deposits had disappeared, the penumbra zone had recovered from 
injury and the necrotic area was partially repaired (Liévens et al., 2000). In this scenario, 
compensatory mechanisms helped normalize Ca2+ homeostasis and avoid further neuronal 
death. The tissue recovered the ability to use extrusion mechanisms, and re-solubilization of 
Ca2+ precipitates took place. 
When Ca2+ deposits are localized extracellularly due to cell death, a microglial reaction is 
activated for their phagocytic removal. This microglial reaction also participates in the 
neuronal death seen in chronic neurodegenerative processes, but is dissociated from 
astrogliosis. In some animal models of neurodegeneration, a recovery has been observed 
associated with the disappearance of Ca2+ deposits. In other excitotoxic rodent models, the 
on-going neurodegenerative process increased with time and the Ca2+ deposits remained 
present, associated with microglial reaction. 
2.4 The calcification process and ageing 
In the neonate mammalian brain, considered more resistant to hypoxia-ischemia than adult 
CNS, dysregulation of Ca2+ homeostasis together with lactate acidosis are considered the 
main factors causing neuronal death. As premature-neonates are more resistant to hypoxia-
ischemia than term neonates, we studied the relationship between differences in human 
brain vulnerability to hypoxia-ischemia during the perinatal period and brain calcification 
in the basal ganglia, cerebral cortex, and hippocampus (Rodríguez et al., 2001). The number 
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and size of the observed non-arteriosclerotic calcifications were area-specific and increased 
in term neonates (Figure 3). The basal ganglia presented the highest degree of calcification 
and the hippocampus the lowest, mainly in the CA1 subfield. In all cases, neuronal damage 
was associated with astroglial reaction and Ca2+ precipitates, with microglial reaction absent 
in the hippocampus. These data are consistent with those obtained following long-term 
excitotoxic lesions in adult rat brain and support the involvement of excitotoxic processes in 
hypoxia-ischemia damage.  
A comparison between lifespan and degree of calcification (Figure 3) demonstrated that in 
all cases, highest calcification occurred within two months of hypoxia-ischemia, and that 
semi-calcification time was very short (less than 10 days). Independent of subjective 
measurements, this last parameter suggests that calcification depends on the degree of brain 
differentiation and initial cerebral injury, but not on the time-course of the lesion. Moreover, 
the mechanisms leading to Ca2+ precipitation seem to be similar for all brain areas. If this is 
true, neurons of each CNS structure degenerate through a common mechanism, which is 
linked to disturbances in Ca2+ homeostasis. As each area of the brain participates in specific 
physiological functions, the resultant pathology will depend on the specific neuronal death 
of the area affected. 
Aging increases neuronal vulnerability to toxic compounds, including drugs that impair 
energy metabolism and induce secondary excitotoxic processes (Brouillet et al., 1993). 
However, a decreased susceptibility of aged rats to excitotoxins such as quinolinic or kainic 
acids has been reported (Kesslak et al., 1995). AMPA-induced Ca2+ deposits in rat 
hippocampus are age-dependent, since young rats (3 months old) present greater areas of 
calcification than middle-aged ones (15 months old) (Bernal et al., 2000a). In this study, glial 
reaction, Ǆ-aminobutiric acid (GABA)-uptake activity and immunostaining of Ca2+ binding 
proteins showed the same response. Therefore, the vulnerability of hippocampal neurons to 
AMPA-induced neurodegeneration decreases with age between 3 and 15 months. Similar 
results have been found in other brain areas, such as the striatum and the nucleus basalis 
magnocellularis. This reduced vulnerability may be related to several factors: for example, 
age-associated variations in the relative abundance of glutamate receptors and pre-synaptic 
alterations of glutamate release may explain, at least in part, an increased resistance to 
excitotoxicity in the hippocampus (Mullany et al., 1996, Nicolle et al., 1996). 
This effect is compatible with the increased vulnerability to excitotoxicity observed in the 
oldest animals (Brouillet et al., 1993), since some of the factors responsible for injury 
resistance may follow a biphasic pattern, with a progressive increase until reaching maturity 
followed by a subsequent decrease (Coleman et al., 1990). Many authors have also described 
biphasic variations in several parameters during aging, with an opposite tendency before 
and after middle age (Villa et al., 1994). We observed a biphasic variation in monoamine 
oxidase B (MAO-B) during aging in most human brain areas: up to the age of 50-60 years 
old, MAO-B levels remain constant, but start to increase thereafter (Saura et al., 1997). This 
finding may be due to the presence of MAO-B rich reactive astrocytes in response to 
neuronal degeneration. A similar increase in plaque-associated astrocytes has been found in 
patients with AD (Saura et al., 1994). As MAO-B activity is associated with reactive oxygen 
species production, astrocytes may contribute to the age-associated decline of neurological 
functions. The evidence that an increase in AMPA receptor correlates negatively with MAO-
B in age-associated learning-impaired rats also suggests that a gliopathic reaction may be 
involved in neuronal dysfunction (Andrés et al., 2000). 
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Fig. 3. Calcification depends on the brain area but also on the glutamate receptor involved. 
a) AMPA induces small calcium deposits in the rat hippocampus, affecting mainly the CA1 
radiatum and lacunosum moleculare subfields. b) AMPA microinjection in the globus 
pallidus induces larger calcium deposits. c) NMDA microinjection in the hippocampus 
induces the formation of large calcium deposits located mainly in the pyramidal CA1 and 
granual dentate gyrus. d) The plots show comparison of the AMPA dose-response study in 
the hippocampus and the globus pallidus. e-f) Correlation plots of the hypoxia ischemia-
induced calcification in the basal ganglia e), cerebral cortex f) and hippocampus g) of 
premature and term neonates. Calcification was calculated in a representative area (1 mm2) 
and the lifespan corresponds to the time of injury in days. k, days to reach half of the 
maximal calcified area. Bars, 300 μm 
Thus, the correlation between the calcification process, neuronal loss and the extent of CNS 
injury disappears with aging, but differences in CNS area vulnerability to calcification are 
maintained. The components that underlie the specific vulnerability of each brain area are 
thus already expressed in human neonates. The permanent area differences are associated 
with significant variations in the response to specific Ca2+ channel blockers such as 
nimodipine and TMB-8 (Bernal et al., 2009, Petegnief et al., 2004), and illustrate the 
functional diversity of each area and the difficulty encountered in ensuring the efficacy of 
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such types of treatment. Similar results concerning differences between calcium precipitates 
and brain area susceptibility have been observed in congenital toxoplasmosis (Safadi et al., 
2003, Surendrababu et al., 2006). Cerebral calcification has been described in 65% of these 
patients, with calcified foci distributed predominantly in the cortex in the form of tiny 
flecks, and as linear streaks in the basal ganglia. 
The calcification process can thus be considered a new stage in cytoplasmic calcium 
homeostasis taking place in a diversity of CNS injuries to reduce calcium signalling at no 
energy cost. When located extracellularly due to cell-death, these precipitates activate a 
permanent microglial reaction aimed at their removal but which rapidly turns into chronic 
damage and aggravation of neurodegeneration. 
2.5 Uncoupling of retaliatory systems and energy availability 
The balance between retaliatory system actions and energy metabolism constitutes a fine 
equilibrium in physiological conditions, but it can be disrupted by glutamate-mediated 
neuronal injury to then participate in the evoked neurodegenerative process. For example, 
AMPA-microinjection in medial septum induces a progressive cholinergic and GABAergic 
loss associated with a long-term decline of the hippocampal functions and decreased 
glutamatergic activity (Rodriguez et al., 2005). Other effects of this lesion imply 
modifications of adenosine and taurine transmissions, glutamate recycling and glucose 
metabolism (Ramonet et al., 2004, Rodriguez et al., 2005). Over time, adenosine replaces 
GABA functions to avoid further excitotoxic damage when cholinergic and GABAergic 
processes are compromised. 
Long-term septal lesion-induced neuronal loss in the hippocampus is apoptotic, with 
enhancement of neuronal glycolysis. Together with the cleavage of caspase 3, a glutamate-
glutamine cycle displacement towards glutamine production reduces glutamate synthesis 
(Ramonet et al., 2004). In addition, synaptic glutamine is decreased, probably through 
expulsion to vessels, where it exerts a vasodilatory effect through NO synthesis inhibition 
(Mates et al., 2002). In this scenario, the reduction in glutamate signaling and increased 
neuronal energy metabolism both reflect a neurodegenerative process with deficient 
adaptation of the retaliatory systems and a chronic energy requirement to execute the 
apoptotic program. 
This chronic energy requirement induces mitochondrial damage, in turn leading to acidosis 
in cells and the extracellular space (Hertz, 2008). Mitochondrial damage forces the cell to 
shift from an aerobic to an anaerobic metabolism, and as a result lactate is produced with 
the formation of two ATPs and the release of two protons. After trauma and ischemia, 
extracellular lactate increases dramatically and pH decreases. To ensure neuronal viability 
during and even after human hypoxia, glial glucose is only oxidized to lactate, which is 
rapidly transported into neurons for its complete oxidation (Sibson et al., 1998). In parallel, a 
Ca2+ influx causes rapid cytoplasmic acidification (Verkhratsky, 2007) through: a) activation 
of membrane Na+/H+ exchanger to restore the Na+ gradient, and b) the Ca2+-dependent 
displacement of protons bound to cytoplasmic anions (Arundine & Tymianski, 2004). 
Furthermore, H+ also appears during some chemical reactions, such as phospholipid 
hydrolysis. 
2.6 Functional relevance of the calcification process 
The massive astroglial production of lactate to help compensate for the neuronal energy 
depletion caused by excitotoxicity is a key factor in brain calcification (Figure 4). pH 
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reduction associated with increased lactate concentration facilitates solubility of Ca2+ and 
the formation of H2PO4-, HPO42- and PO43- ions from inorganic phosphate (Rodriguez et al., 
2000) and phosphorylated proteins. Because of the very high Ca2+ / H2PO4-, HPO42-, PO43- 
affinity, apatite nucleation may occur, with the subsequent growth of crystalline formations 
together with neurodegeneration. In this case, calcification of each lesioned area will also 
depend on phosphate availability and the differential capacity of glial cells to release lactate 
during degeneration. 
Wide variations have been described in the extent of calcification in pathological cases 
(Ramonet et al., 2002, Rodríguez et al., 2001) and animal species (Ramonet et al., 2006) 
However, the homogeneous morphology of these deposits suggests common synaptic 
processes (Ramonet et al., 2006) where variability depends on cellular type (astrocyte or 
neuron), glutamatergic activity, and energy availability (Figure 4). These factors modify Ca2+ 
homeostasis and may trigger cellular calcification through a common mechanism (Ramonet 
et al., 2006). Thus, hydroxyapatite formation, with the subsequent reduction of free Ca2+ ions, 
may take place as an alternative homeostatic step to reduce excitotoxicity (Ramonet et al., 
2006, Rodriguez et al., 2000), and a number of findings lend support to this interpretation. 
For example, it has been observed that mitochondria close to Ca2+ deposits appear  
normal at electron microscopy level (Mahy et al., 1999, Rodriguez et al., 2000), despite 
 
 
Fig. 4. Excitotoxicity modifies cell calcium homeostasis in the brain. Drawing of the 
excitotoxic process induced by glutamate, with the intercellular precipitation of calcium as 
part of the calcium homeostasis. The metabolic pathway of lactate with the communication 
between endothelial, astroglial, microglial and neuronal compartments is included in the 
diagram 
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the fact that mitochondrial dysfunction constitutes a primary event in NMDA-induced 
degeneration (Schinder et al., 1996). This hypothesis is also consistent with the finding that 
neurons undergoing prolonged stimulation of NMDA receptors can survive in the presence 
of [Ca2+]i chelators. Very high levels of cytoplasmic Ca2+ are not necessarily neurotoxic, and 
an effective uptake of this element into mitochondria is required to trigger NMDA-receptor-
stimulated neuronal death (Stout et al., 1998). Moreover, in rat globus pallidus, an AMPA-
dose-response study has shown a dose-dependent increase in calcification, which was not 
accompanied by an increase in astrogliosis (Petegnief et al., 1999). In the hippocampus, 
AMPA induced a calcified area larger than the injured area. In this same structure, the 
selective adenosine-A2a-receptor antagonist 8-(3-chlorostyryl)-caffeine increased NMDA-
induced neuronal loss while calcification was decreased (Robledo et al., 1999). All these data 
indicate that Ca2+ precipitation does not necessarily reflect neuronal death and that, as 
proposed for retinal excitotoxic damage (Chen et al., 1999), in addition to Ca2+ other factors 
such as Na+ and Cl- influx, cell swelling and acidosis induce excitotoxic neuronal damage. 
3. Conclusions 
Neurodegenerative disorders are characterized by the appearance of distinct 
neurodegenerative parameters that determine the induction of a chronic process with 
underlying glutamate-mediated excitotoxicity and Ca2+ dys-homeostasis. At tissue level, the 
pathogenesis of each disorder depends on the neuronal type involved, synaptic density, 
glial interactions, and vicinity of vascularization. For each neuron, astrocyte and microglial 
type, the group of glutamate and cytokine receptors, the Ca2+ binding protein content, 
protein phosphorylation levels, and all elements that participate in energy needs and 
glucose availability will constitute the factors involved in the appearance of the lesion. In 
this scenario, CNS calcification can be considered one of the few common mechanisms 
already available at an early age to help buffer disturbances in Ca2+ homeostasis at no 
energy cost. Over time, CNS maturation includes a massive increase in synaptic 
connections, the organization of inhibitory systems and greater cellular complexity. As it 
becomes more sophisticated, the CNS relies on a greater diversity of mechanisms to prevent 
CNS injury. This would explain why calcification is observed in neurodegenerative diseases, 
but does not correlate with CNS damage. 
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